ABSTRACT
The present study evaluates the antioxidant and cytotoxic activity of Zanthonitrile isolated from Zanthoxylum alatum leaves. The structure of Zanthonitrile [{4-[(3-Methyl-2-buten-1-yl) oxy] phenyl} acetonitrile] was elucidated form the data obtained from UV, IR, Mass, and NMR. The in vitro antioxidant activity of Zanthonitrile was estimated by standard 1, 1-diphenyl-2-picrylhydrazil radical (DPPH) scavenging assay method. In vitro cytotoxicity was determined in Ehrlich Ascites Carcinoma (EAC) cells by MTT assay. The compound exhibited antioxidant activity in a dose dependent manner. The IC50 value of Zanthonitrile for DPPH was estimated to be 7.86 ± 0.23 μg/mL. Zanthonitrile showed satisfactory cytotoxic potential in MTT assay with the IC50 value 57.28 ± 0.64 μg/mL. Satisfactory results of both the studies correlate each other and further investigations will focus on in vivo models and cell cycle to determine the role on intrinsic and extrinsic apoptotic pathways.
ABSTRACT
Methanol extract of C. indica (MECI) leaves showed direct cytotoxicity on Ehrlich ascites carcinoma (EAC) cell in a dose dependant manner and there was significant decrease in the tumor volume, viable cell count, tumor weight and elevated the life span of EAC tumor bearing mice. Hematological profile and biochemical estimations were significantly restored to normal levels in MECI treated as compared to EAC control mice. MECI treatment significantly modulated the tissue antioxidant assay parameters as compared to the EAC control mice. The results revealed that MECI possesses significant dose dependent antitumor potential which may be due to its cytotoxicity and antioxidant properties.
ABSTRACT
Purpose: Dregea volubilis Benth, commonly known as Jukti in Bengal, is used in the treatment of boils and abscesses from ancient times. The purpose of this study is to elucidate the active compounds and as well as their anti-leishmanial and anti-tumour activities. Methods: Dried and crushed fruits of Dregea volubilis were extracted by petroleum ether (40 - 60°C); the best solvent system had first been verified by analytical Thin Layer Chromatography (TLC). The extract was subjected to TLC and column chromatography (CC) to isolate the pure compounds. Spectra data were obtained by Infra Red pectroscopy, Mass Spectroscopy and Nuclear Magnetic Resonance - Proton Magnetic Resonance (PMR), Carbon Magnetic Resonance (CMR) and Distortionless Enhancement by Polarization Transfer (DEPT) - for structure elucidation of the isolated compound(s). One of the compounds isolated was screened for anti-leishmanial activity against promastigotes of Leishmania donovani and anti-tumour activity on K562 leukemic cell line. Results: A pentacyclic triterpenoid compound was isolated and designated as taraxerone, and then characterized as d-friedoolean-14-en, 3 one together with ß-sitosterol and a long chain lipid fraction.. This compound showed in vitro anti-leishmanial activity against promastigotes of Leishmania donovani(strain AG 83) and anti-tumour activity on K562 leukemic cell line. Conclusion: A pentacyclic triterpenoid compound designated as taraxerone and characterized as Dfriedoolean-14-en, 3 one together was successfully isolated. The structure was determined on the basis of spectral analysis (IR, MASS, NMR (PMR, CMR and DEPT) and the compound demonstrated in vitro anti-leishmanial and anti-tumour activities